Insights On Pharmaceutical Packaging
-
Characterizing The E&L Profile Of Stoppers For Drug Stability
6/11/2024
The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.
-
4 Things To Consider In Pharmaceutical Labeling
12/11/2024
Pharmaceutical labeling demands precision. Examine key considerations for ensuring accuracy and efficiency in your process, from robust control systems to diverse printing options.
-
A Robust Extractables Data Package Helps Drive Patient Safety
10/1/2024
Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
2/20/2024
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
Step Into The Future Of ATMP Fill-Finish
5/21/2025
Discover the future of ATMP manufacturing as Josh Russell from AST demonstrates an advanced, fully automated fill-finish system featuring automated bag and tub opening, as well as the Atmos isolator.
-
Why Compounding Pharma Manufacturers Should Evaluate BFS Systems
12/5/2024
Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.
-
Providing Packing And Blinding Solutions For An Innovative Drug Start-Up
9/13/2024
Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.
-
Navigating Primary Packaging Challenges, Solutions For Emerging Innovators
12/5/2024
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
-
Integration Of Container Closure Integrity In Contract Manufacturing
3/28/2025
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
Alba® Syringe Platform: Ensuring Stability For Sensitive Drugs
1/13/2025
Check out this exciting video showcasing the key advantages of Alba®: innovative coating technology that reduces potential interaction between the drug and container surface.